Skip to main content

Nitric Oxide Synthase Inhibitors and Cerebral Vasospasm

  • Conference paper
Early Brain Injury or Cerebral Vasospasm

Part of the book series: Acta Neurochirurgica Supplements ((NEUROCHIRURGICA,volume 110/1))

  • 1418 Accesses

Abstract

l-arginine is a source of nitric oxide (NO) that is cleaved from the terminal guanidino nitrogen atom by nitric oxide synthase (NOS). NO evokes, because of its free radical properties and affinity to heme, ferrous iron and cysteine, a wide spectrum of physiological and pathophysiological effects. For many years, different exogenous NOS inhibitors were used to elucidate the role of NOS and NO in health and disease. Later, endogenous NOS inhibitors, as asymmetric dimethylarginine (ADMA) were discovered. Endogenous inhibitors as ADMA are produced by post-translational methylation of l-arginine which is catalyzed by a family of protein N-methyltransferases (PRMT), using S-adenosylmethionine as a methyl group donor. ADMA is eliminated by dimethylarginine dimethylaminohydrolases (DDAH I or II). ADMA hydrolysis increases NOS activity and NO production. Furthermore, l-citrulline, a by-product of ADMA hydrolysis as well as of NO production by NOS, can in turn inhibit DDAH. Therefore, endogenous inhibition of NOS can be modified via different ways (1) changing the availability of l-arginine and/or of l-citrulline; (2) stimulating or inhibiting DDAH activity; (3) modifying methylation via regulating availability of adenosylmethionine; or (4) modifying PRMT activity. Research elucidating the role of NOS inhibitors in respect of delayed cerebral vasospasm after subarachnoid hemorrhage is summarized.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001;124:249–78.

    Article  PubMed  Google Scholar 

  2. Iadecola C, Zhang F, Xu X. Role of nitric oxide synthase-containing vascular nerves in cerebrovasodilation elicited from cerebellum. Am J Physiol. 1993;264:R738–46.

    PubMed  CAS  Google Scholar 

  3. Pluta RM, Thompson JG, Dawson TM, Snyder SH, Book RJ, Oldfield EH. Loss of nitric oxide synthase immunoreactivity in cerebral vasospasm. J Neurosurg. 1996;84:648–54.

    Article  PubMed  CAS  Google Scholar 

  4. Toda N, Tanaka T, Ayajiki K, Okamura T. Cerebral vasodilatation induced by stimulation of the pterygopalatine ganglion and greater petrosal nerve in anesthetized monkeys. Neuroscience 2000;96:393–8.

    Article  PubMed  CAS  Google Scholar 

  5. Hirose H, Ide K, Sasaki T, Takahashi R, Kobayashi M, Ikemoto F, et al. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Eur J Pharmacol. 1995;277:77–87.

    Article  PubMed  CAS  Google Scholar 

  6. Hibbs JB, Jr., Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988;157:87–94.

    Article  PubMed  CAS  Google Scholar 

  7. Sobey CG, Faraci FM. Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol. 1998;25:867–76.

    Article  PubMed  CAS  Google Scholar 

  8. Ignarro LJ. Nitric oxide as a unique signaling molecule in the vascular system: a historical overview. J Physiol Pharmacol. 2002;53:503–14.

    PubMed  CAS  Google Scholar 

  9. McAllister RJ, Parry H, Kimoto M, Ogawa T, Russell RJ, Hodson H, et al. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol. 1996;119:1533–40.

    Article  PubMed  CAS  Google Scholar 

  10. Park KW, Metais C, Dai HB, Comunale ME, Sellke FW. Microvascular endothelial dysfunction and its mechanism in a rat model of subarachnoid hemorrhage. Anesth Analg. 2001;92:990–6.

    Article  PubMed  CAS  Google Scholar 

  11. Hino A, Tokuyama Y, Weir B, Takeda J, Yanc H, Bell GI, et al. Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys. Neurosurgery 1996;39:562–7; discussion 567–568.

    PubMed  CAS  Google Scholar 

  12. Kasuya H, Weir BK, Nakane M, Pollock JS, John L, Marton LS, et al. Nitric oxide synthase and guanylate cyclase levels in canine basilar artery after subarachnoid hemorrhage. J Neurosurg. 1995;82:250–5.

    Article  PubMed  CAS  Google Scholar 

  13. Iuliano BA, Pluta RM, Jung C, Oldfield EH. Endothelial dysfunction in a primate model of cerebral vasospasm. J Neurosurg. 2004;100:287–94.

    Article  PubMed  Google Scholar 

  14. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373–6.

    Article  PubMed  CAS  Google Scholar 

  15. Afshar JK, Pluta RM, Boock RJ, Thompson BG, Oldfield EH. Effect of intracarotid nitric oxide on primate cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 1995;83:118–22.

    Article  PubMed  CAS  Google Scholar 

  16. Pluta RM, Oldfield EH, Boock RJ. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage. J Neurosurg. 1997;87:746–51.

    Article  PubMed  CAS  Google Scholar 

  17. Jung CS, Iulianc B, Harvey-White J, Espey M, Oldfield EH, Pluta PM. Association between cerebrospinal fluid levels of asymmetric dimethyl-l-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage. J Neurosurg. 2004;101:836–42.

    Article  PubMed  CAS  Google Scholar 

  18. Jung CS, Oldfield EH, Harvey-Wuik J, Espey MG, Zimmermann M, Seifert V, et al. Association of an endogenous inhibitor of nitric oxide synthase with cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg. 2007;107:945–50.

    Article  PubMed  CAS  Google Scholar 

  19. Marhus-Lobeuholter J, Sulyok E, Creikr E, Buki A, Kohl J, Firsching R. Determination of cerebrospinal fluid concentrations of arginine and dimethylarginines in patients with subarachnoid haemorrhage. J Neurosci Methods. 2007;164:155–60.

    Article  PubMed  CAS  Google Scholar 

  20. Kakimoto Y, Akazawa S. Isolation and identification of N-G,N-G- and N-G,N’-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine. J Biol Chem. 1970;245:5751–8.

    PubMed  CAS  Google Scholar 

  21. Boisvert FM, Cote J, Boulanger MC, Richard S. A proteomic analysis of arginine-methylated protein complexes. Mol Cell Proteomics. 2003;2:1319–30.

    Article  PubMed  CAS  Google Scholar 

  22. Tang J, Frankel A, Cook RJ, Kim S, Paik WK, Williams KR, et al. PRMT1 is the predominant type I protein arginine methyltransferase in mammalian cells. J Biol Chem. 2000;275:7723–30.

    Article  PubMed  CAS  Google Scholar 

  23. Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, et al. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res. 2000;87:99–105.

    Article  PubMed  CAS  Google Scholar 

  24. Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GS, et al. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem J. 1999;343 Pt 1:209–14.

    Article  PubMed  CAS  Google Scholar 

  25. Chardonnel AJ, Cui H, Samouilov A, Johnson AW, Kearns P, Tsai AL, et al. Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J Biol Chem. 2007;282:879–87.

    Article  PubMed  CAS  Google Scholar 

  26. McDermott JR. Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. Biochem J. 1976;154:179–84.

    PubMed  CAS  Google Scholar 

  27. Vallance P. Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet 2001;358:2096–7.

    Article  PubMed  CAS  Google Scholar 

  28. Kamper AM, Spilt A, de Craen AJ, van Buchem MA, Westendorp RG, Blauw GJ. Basal cerebral blood flow is dependent on the nitric oxide pathway in elderly but not in young healthy men. Exp Gerontol. 2004;39:1245–8.

    Article  PubMed  CAS  Google Scholar 

  29. White RP, Hindley C, Bloomfield PM, Cunningham VJ, Valiance P, Brooks DJ, et al. The effect of the nitric oxide synthase inhibitor l-NMMA on basal CBF and vasoneuronal coupling in man: a PET study. J Cereb Blood Flow Metab. 1999;19:673–8.

    Article  PubMed  CAS  Google Scholar 

  30. Kielstein JT, Donnerstag F, Gasper S, Menne J, Kielstein A, Martens-Lobenhoffer J, et al. ADMA increases arterial stiffness and decreases cerebral blood flow in humans. Stroke 2006;37:2024–9.

    Article  PubMed  Google Scholar 

  31. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572–5.

    Article  PubMed  CAS  Google Scholar 

  32. Faraci FM, Brian JE, Jr., Heistad DD. Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase. Am J Physiol. 1995;269:H1522–7.

    PubMed  CAS  Google Scholar 

  33. Segarra G, Medina P, Ballester RM, Lluch P, Aldasoro M, Vila JM, et al. Effects of some guanidino compounds on human cerebral arteries. Stroke 1999;30:2206–10; discussion 2210–2211.

    Article  PubMed  CAS  Google Scholar 

  34. Osanai T, Saitoh M, Sasaki S, Tomita H, Matsunaga T, Okumura K. Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells. Hypertension 2003;42:985–90.

    Article  PubMed  CAS  Google Scholar 

  35. Ito A, Tsao PS, Adimoolam S, Kimoto M, Ogawa T, Cooke JP. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 1999;99:3092–5.

    Article  PubMed  CAS  Google Scholar 

  36. Jiang JL, Li NS, Li YJ, Deng HW. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. Br J Pharmacol. 2002;135:1175–82.

    Article  PubMed  CAS  Google Scholar 

  37. Pluta RM, Jung CS, Harvey-White J, Whitehead A, Shilad S, Espey MG, et al. In vitro and in vivo effects of probucol on hydrolysis of asymmetric dimethyl l-arginine and vasospasm in primates. J Neurosurg. 2005;103:731–8.

    Article  PubMed  CAS  Google Scholar 

  38. Piatti P, Fragasso G, Monti LD, Setola E, Lucotti P, Fermo I, et al. (2003) Acute intravenous l-arginine infusion decreases endothelin-1 levels and improves endothelial function in patients with angina pectoris and normal coronary arteriograms: correlation with asymmetric dimethylarginine levels. Circulation 2001;107:429–36.

    Article  PubMed  CAS  Google Scholar 

  39. Willmot M, Gray L, Gibson C, Murphy S, Bath PM. A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 2005;12:141–9.

    Article  PubMed  CAS  Google Scholar 

  40. Goksel HM, Ozum U, Oztoprak I. The therapeutic effect of continuous intracisternal l-Arginine infusion on experimental cerebral vasospasm. Acta Neurochir (Wien). 2001;143:277–85.

    Article  CAS  Google Scholar 

  41. Kajita Y, Suzuki Y, Oyama H, Tanatawa T, Takayasu M, Shibuya M, et al. Combined effect of l-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg. 1994;80:476–83.

    Article  PubMed  CAS  Google Scholar 

  42. Pluta RM, Afshar JK, Thompson BG, Book RJ, Harvey-White J, Oldfield EH. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to l-arginine infusion after subarachnoid hemorrhage. J Neurosurg. 2000;92:121–6.

    Article  PubMed  CAS  Google Scholar 

  43. Lentz SR, Rodionov RN, Dayal S. Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA. Atheroscler Suppl. 2003;4:61–5.

    Article  PubMed  CAS  Google Scholar 

  44. Maas R. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA). Vasc Med. 2005;10 Suppl 1:S49–57.

    Article  PubMed  Google Scholar 

  45. Leiper J, Nandi M, Torondel B, Murray-Rust J, Malaki M, O’Hara B, et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med. 2007;13:198–203.

    Article  PubMed  CAS  Google Scholar 

  46. Dayoub H, Achan V, Adimoolam S, Jacob J, Stuehliuger MC, Wang BY, et al. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 2003;108:3042–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. S. Jung .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag/Wien

About this paper

Cite this paper

Jung, C.S. (2011). Nitric Oxide Synthase Inhibitors and Cerebral Vasospasm. In: Feng, H., Mao, Y., Zhang, J.H. (eds) Early Brain Injury or Cerebral Vasospasm. Acta Neurochirurgica Supplements, vol 110/1. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0353-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-0353-1_16

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-0352-4

  • Online ISBN: 978-3-7091-0353-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics